INSPECS Group plc (AIM:SPEC)
United Kingdom flag United Kingdom · Delayed Price · Currency is GBP · Price in GBX
87.00
-1.50 (-1.69%)
Nov 6, 2026, 1:21 PM GMT

INSPECS Group Revenue

INSPECS Group had revenue of 99.15M GBP in the half year ending June 30, 2026, a decrease of -1.45%. This brings the company's total for the last twelve months to 193.23M, up 1.51% year-over-year. In the year 2025, INSPECS Group had annual revenue of 191.70M, down -0.85%. That makes INSPECS Group the 15,609th largest company in the world by revenue and 357th in the United Kingdom.

Revenue (ttm)
193.23M
Revenue Growth
+1.51%
P/S Ratio
0.49
Revenue / Employee
116.68K
Employees
1,656
Market Cap
94.98M

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Frames and Optics 175.44M 88.9%
  • Manufacturing 21.94M 11.1%

By Geography

Chart
  • Europe (Excluding UK) 87.52M 45.7%
  • North America 72.12M 37.6%
  • United Kingdom 19.22M 10.0%
  • Australia 6.43M 3.4%
  • Asia 4.09M 2.1%
  • South America 2.05M 1.1%
  • Africa 268.00K 0.1%
Fiscal year ended Dec 31, 2025 See the full INSPECS Group breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025191.70M-1.64M-0.85%
Dec 31, 2024193.35M-9.95M-4.89%
Dec 31, 2023203.29M2.34M1.16%
Dec 31, 2022200.96M18.65M10.23%
Dec 31, 2021182.30M147.62M425.66%
Dec 31, 202034.68M-11.51M-24.91%
Dec 31, 201946.19M1.20M2.67%
Dec 31, 201844.98M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
AstraZeneca46.99B
GSK plc33.54B
Haleon11.15B
Smith & Nephew4.77B
Kooth62.02M
Allergy Therapeutics57.29M
EKF Diagnostics Holdings51.35M
Venture Life Group35.27M
Revenue Rankings